Orakl Oncology

Orakl Oncology

Intelligence artificielle / Machine Learning, Pharmaceutique / Biotechnologique

Le Kremlin-Bicêtre, Paris

Présentation

🔮 Less than 5% of new cancer drugs successfully make it through clinical trials. Clearly, new methods are needed to transform oncology research and improve patient care. Orakl Oncology is a techbio startup accelerating drug discovery and development through innovative tumor avatars. The company was established in 2023 as a spin-out from Gustave-Roussy, a leading European cancer research institute based on 10 years of research by Orakl’s CEO, Dr. Fanny Jaulin, and her laboratory.

🧪 Orakl Oncology is pioneering the use of its patient tumor avatar technology to anticipate clinical trial outcomes. We create an avatar for each patient’s tumor, combining clinical and molecular data alongside proprietary organoids, at scale, and predict patient response in the clinic. Powered by lab automation and machine learning, we discover and validate new targets, drugs, and predictive biomarkers. The VC-backed company is growing fast, and we are now seeking the best talents to come and join our exciting and ambitious team in the fight against cancer!

Bon à savoir

📈 Fundraising
Orakl Oncology successfully raised €11 million in December 2024, following an initial €3 million fundraising round in 2023 with European funds (Singular, Speedinvest, HCVC, Verve and BPI France)

👶 Founders
+20 years experience with complementary backgrounds (PhD, X, Cambridge, HEC, leading research at Gustave Roussy, 1st cancer center in Europe)

💼 Team
Our diverse global team comes from across Europe and brings expertise from various backgrounds, including biology, software engineering, and strategic consulting.

🏢 Office
Our offices are currently located in Kremlin-Bicêtre and in the city center, offering a stunning view of Notre-Dame. We will soon relocate to the Paris-Saclay Cancer Cluster (PSCC) to take full advantage of its dynamic ecosystem, fostering collaboration between academic institutions, hospitals, biotech and techbio companies, and pharmaceutical firms.

Ce qu'ils recherchent

Orakl Oncology is experiencing rapid growth and is expanding multiple teams, including:

🌍 Business team including a Sr. BD and a Manager

💾 Dry lab team including a Senior Software Engineer and a Senior Bioinformatician

👩‍🔬 Wet lab including a Lab Technicians and Research assistants

💍 Operational team including a legal expert and a head of operations

Intégrer ce profil sur votre site